newsfilter
← Latest News
Business Wire·

SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting determination letter (the